# Lyne Laboratories, Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c

> Inspection records and compliance data for Lyne Laboratories, Inc. in Brockton, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Lyne Laboratories, Inc.
- FEI Number: 1000513191
- City: Brockton
- State: Massachusetts
- Country Name: United States
- Address Line 1: 10 Burke Dr
- Zip Code: 02301
- Business Operations: FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1306884 - Lyne Laboratories, Inc. - 2026-03-10](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/df0c3cb3-fb52-41ec-b176-a22d4e1c4bba) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 10, 2026
- [483 - Lyne Laboratories, Inc. - 2022-10-21](https://www.globalkeysolutions.net/records/483/lyne-laboratories-inc/eca42796-26bd-4361-9df3-c0134d5b57f4) — source: FDA, date: October 21, 2022
- [FDA Inspection 1182001 - Lyne Laboratories, Inc. - 2022-10-21](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/3658da10-6945-42f6-913c-925867ca3f56) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 21, 2022
- [FDA Inspection 1152572 - Lyne Laboratories, Inc. - 2021-09-08](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/5b964a73-e1f4-4d6f-aa31-40ec87f5b9e5) — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2021
- [EIR - Lyne Laboratories, Inc. - 2021-09-07](https://www.globalkeysolutions.net/records/eir/lyne-laboratories-inc/1135dafc-6774-4eb2-bf03-3d997c8c8c40) — source: FDA, date: September 7, 2021
- [FDA Inspection 1038819 - Lyne Laboratories, Inc. - 2018-01-25](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/4442e28e-c441-4696-9b59-028352c1ecdf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 25, 2018
- [FDA Inspection 1026803 - Lyne Laboratories, Inc. - 2017-09-07](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/fa3c3de1-a859-429e-b7a8-9663fc187566) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2017
- [FDA Inspection 983497 - Lyne Laboratories, Inc. - 2016-08-17](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/9a3179d0-c534-4a79-b260-24cd70c6ee0d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 17, 2016
- [FDA Inspection 865986 - Lyne Laboratories, Inc. - 2014-02-13](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/e72b846f-db71-450c-a40e-bee48e81a28f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 13, 2014
- [FDA Inspection 713089 - Lyne Laboratories, Inc. - 2011-03-25](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/f665ea98-6433-4025-905d-9b4c3aa8ba07) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2011
- [FDA Inspection 655770 - Lyne Laboratories, Inc. - 2010-04-05](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/e684e1a1-69b6-4d38-ac8b-9642e32104d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2010
- [FDA Inspection 570569 - Lyne Laboratories, Inc. - 2009-02-26](https://www.globalkeysolutions.net/records/fda_inspections/lyne-laboratories-inc/e7da4582-93d3-41f6-8a2d-89cada97070c) — classification: Official Action Indicated (OAI), source: FDA, date: February 26, 2009

## Related Companies

- [AstraZeneca Pharmaceuticals LP](https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b)
- [Viatris Pharmaceuticals LLC](https://www.globalkeysolutions.net/companies/viatris-pharmaceuticals-llc/b3d7bba7-bfc8-4d2b-a517-321f7b518a12)
- [Glaukos Corporation](https://www.globalkeysolutions.net/companies/glaukos-corporation/9e9a7fd4-2158-4073-b5b9-79ba4fbdde83)
- [Janssen Pharmaceuticals Inc.](https://www.globalkeysolutions.net/companies/janssen-pharmaceuticals-inc/b494dc6e-cfeb-46a2-8c10-e036e6a5a623)
- [Catalent Pharma Solutions, LLC](https://www.globalkeysolutions.net/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d)
- [Finish Line Horse Products, Inc.](https://www.globalkeysolutions.net/companies/finish-line-horse-products-inc/205e6869-8995-4e35-9af4-e022b2dedb77)
- [Amgen Technology (Ireland) Unlimited Company](https://www.globalkeysolutions.net/companies/amgen-technology-ireland-unlimited-company/576ab93b-ec8d-4b76-b25c-a1c473d6ae61)
- [Fareva Richmond, Inc.](https://www.globalkeysolutions.net/companies/fareva-richmond-inc/d42f54e3-2fe8-4501-b6ba-43cd66d2f5cb)
- [Organon Pharma (UK) Ltd.](https://www.globalkeysolutions.net/companies/organon-pharma-uk-ltd/5fa8cf74-45d3-45f6-abb3-6918d01961a6)
- [Celgene International Sarl](https://www.globalkeysolutions.net/companies/celgene-international-sarl/4b6c72e0-737a-445e-a238-7c7cc1265e65)

## Related Officers

- [Robert Crisafi](https://www.globalkeysolutions.net/people/robert-crisafi/08ea9792-2d9b-409e-bc11-383da2a4bac3)
- [company_representative](https://www.globalkeysolutions.net/people/robert-walter/4baa46d1-1b6f-4a04-992f-2568a0f1a302)
- [M.S., Consumer Safety Officer at FDA](https://www.globalkeysolutions.net/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)